Table of Contents

- R C McDonald
The evolving care of diabetes. Models, managed care, and public health.
Diabetes Care May 1997 20:685-686
Select this article
- P Segal,
- P U Feig,
- G Schernthaner,
- K P Ratzmann,
- J Rybka,
- D Petzinna,
- and C Berlin
The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone.
Diabetes Care May 1997 20:687-691; doi:10.2337/diacare.20.5.687
- Abstract
Select this article
- P Sundaresan,
- D Lykos,
- A Daher,
- T Diamond,
- R Morris,
- and L G Howes
Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM.
Diabetes Care May 1997 20:692-697; doi:10.2337/diacare.20.5.692
- Abstract
Select this article
- I M el-Kebbi,
- D C Ziemer,
- V C Musey,
- D L Gallina,
- A M Bernard,
- and L S Phillips
Diabetes in urban African-Americans. IX. Provider adherence to management protocols.
Diabetes Care May 1997 20:698-703; doi:10.2337/diacare.20.5.698
- Abstract
Select this article
- B Y Chun,
- A J Dobson,
- and R F Heller
The impact of diabetes on survival among patients with first myocardial infarction.
Diabetes Care May 1997 20:704-708; doi:10.2337/diacare.20.5.704
- Abstract
Select this article
- R L Chaiken,
- R Khawaja,
- M Bard,
- M Eckert-Norton,
- M A Banerji,
- and H E Lebovitz
Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects.
Diabetes Care May 1997 20:709-713; doi:10.2337/diacare.20.5.709
- Abstract
Select this article
- H B Mortensen and
- P Hougaard
Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes.
Diabetes Care May 1997 20:714-720; doi:10.2337/diacare.20.5.714
- Abstract
Select this article
- M Salerno,
- A Argenziano,
- S Di Maio,
- N Gasparini,
- S Formicola,
- G De Filippo,
- and A Tenore
Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control.
Diabetes Care May 1997 20:721-724; doi:10.2337/diacare.20.5.721
- Abstract
Select this article
- R C Eastman,
- J C Javitt,
- W H Herman,
- E J Dasbach,
- A S Zbrozek,
- F Dong,
- D Manninen,
- S A Garfield,
- C Copley-Merriman,
- W Maier,
- J F Eastman,
- J Kotsanos,
- C C Cowie,
- and M Harris
Model of complications of NIDDM. I. Model construction and assumptions.
Diabetes Care May 1997 20:725-734; doi:10.2337/diacare.20.5.725
- Abstract
Select this article
- R C Eastman,
- J C Javitt,
- W H Herman,
- E J Dasbach,
- C Copley-Merriman,
- W Maier,
- F Dong,
- D Manninen,
- A S Zbrozek,
- J Kotsanos,
- S A Garfield,
- and M Harris
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.
Diabetes Care May 1997 20:735-744; doi:10.2337/diacare.20.5.735
- Abstract
Select this article
- T R Gaillard,
- D P Schuster,
- B M Bossetti,
- P A Green,
- and K Osei
The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
Diabetes Care May 1997 20:745-752; doi:10.2337/diacare.20.5.745
- Abstract
Select this article
- G R Law,
- P A McKinney,
- A Staines,
- R Williams,
- M Kelly,
- F Alexander,
- E Gilman,
- and H J Bodansky
Clustering of childhood IDDM. Links with age and place of residence.
Diabetes Care May 1997 20:753-756; doi:10.2337/diacare.20.5.753
- Abstract
Select this article
- D M Berinstein,
- R M Stahn,
- T K Welty,
- G R Leonardson,
- and J J Herlihy
The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians.
Diabetes Care May 1997 20:757-759; doi:10.2337/diacare.20.5.757
- Abstract
Select this article
- G W Welch,
- A M Jacobson,
- and W H Polonsky
The Problem Areas in Diabetes Scale. An evaluation of its clinical utility.
Diabetes Care May 1997 20:760-766; doi:10.2337/diacare.20.5.760
- Abstract
Select this article
- M E Parent,
- J Siemiatycki,
- R Menzies,
- L Fritschi,
- and E Colle
Bacille Calmette-Guérin vaccination and incidence of IDDM in Montreal, Canada.
Diabetes Care May 1997 20:767-772; doi:10.2337/diacare.20.5.767
- Abstract
Select this article
- M E González Villalpando,
- C González Villalpando,
- B Arredondo Pérez,
- S V Martínez Díaz,
- B Mitchell,
- D Rivera Martínez,
- R Klein,
- S M Haffner,
- and M P Stern
Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas.
Diabetes Care May 1997 20:773-777; doi:10.2337/diacare.20.5.773
- Abstract
Select this article
- A J Sinclair,
- I Allard,
- and A Bayer
Observations of diabetes care in long-term institutional settings with measures of cognitive function and dependency.
Diabetes Care May 1997 20:778-784; doi:10.2337/diacare.20.5.778
- Abstract
Select this article
- M M Engelgau,
- T J Thompson,
- W H Herman,
- J P Boyle,
- R E Aubert,
- S J Kenny,
- A Badran,
- E S Sous,
- and M A Ali
Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
Diabetes Care May 1997 20:785-791; doi:10.2337/diacare.20.5.785
- Abstract
Select this article
- R P Stolk,
- M M Breteler,
- A Ott,
- H A Pols,
- S W Lamberts,
- D E Grobbee,
- and A Hofman
Insulin and cognitive function in an elderly population. The Rotterdam Study.
Diabetes Care May 1997 20:792-795; doi:10.2337/diacare.20.5.792
- Abstract
Select this article
- J Pohl,
- G Frohnau,
- W Kerner,
- and G Fehm-Wolfsdorf
Symptom awareness is affected by the subjects' expectations during insulin-induced hypoglycemia.
Diabetes Care May 1997 20:796-802; doi:10.2337/diacare.20.5.796
- Abstract
Select this article
- J Rovet and
- M Alvarez
Attentional functioning in children and adolescents with IDDM.
Diabetes Care May 1997 20:803-810; doi:10.2337/diacare.20.5.803
- Abstract
Select this article
- A M Jacobson,
- S T Hauser,
- J B Willett,
- J I Wolfsdorf,
- R Dvorak,
- L Herman,
- and M de Groot
Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients.
Diabetes Care May 1997 20:811-818; doi:10.2337/diacare.20.5.811
- Abstract
Select this article
- A Solini,
- L Vergnani,
- F Ricci,
- and G Crepaldi
Glycosaminoglycans delay the progression of nephropathy in NIDDM.
Diabetes Care May 1997 20:819-823; doi:10.2337/diacare.20.5.819
- Abstract
Select this article
- M A Di Leo,
- W Di Nardo,
- S Cercone,
- A Ciervo,
- M Lo Monaco,
- A V Greco,
- G Paludetti,
- and G Ghirlanda
Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy.
Diabetes Care May 1997 20:824-828; doi:10.2337/diacare.20.5.824
- Abstract
Select this article
- M Yamamoto,
- G Egusa,
- and M Yamakido
Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM.
Diabetes Care May 1997 20:829-831; doi:10.2337/diacare.20.5.829
- Abstract
Select this article
- I Contreras,
- K M Reiser,
- N Martinez,
- E Giansante,
- T Lopez,
- N Suarez,
- S Postalian,
- M Molina,
- F Gonzalez,
- M R Sanchez,
- M Camejo,
- and M C Blanco
Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.
Diabetes Care May 1997 20:832-835; doi:10.2337/diacare.20.5.832
- Abstract
Select this article
- D Fedele,
- G Comi,
- C Coscelli,
- D Cucinotta,
- E L Feldman,
- G Ghirlanda,
- D A Greene,
- P Negrin,
- and F Santeusanio
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee.
Diabetes Care May 1997 20:836-843; doi:10.2337/diacare.20.5.836
- Abstract
Select this article
- H Yokoyama,
- M Okudaira,
- T Otani,
- H Takaike,
- J Miura,
- A Saeki,
- Y Uchigata,
- and Y Omori
Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications.
Diabetes Care May 1997 20:844-847; doi:10.2337/diacare.20.5.844
- Abstract
Select this article
- T Kawagishi,
- Y Nishizawa,
- M Emoto,
- K Maekawa,
- Y Okuno,
- H Taniwaki,
- M Inaba,
- E Ishimura,
- and H Morii
Gastric myoelectrical activity in patients with diabetes. Role of glucose control and autonomic nerve function.
Diabetes Care May 1997 20:848-854; doi:10.2337/diacare.20.5.848
- Abstract
Select this article
- R M Stess,
- S R Jensen,
- and R Mirmiran
The role of dynamic plantar pressures in diabetic foot ulcers.
Diabetes Care May 1997 20:855-858; doi:10.2337/diacare.20.5.855
- Abstract
Select this article
- F S Nielsen,
- P Gaede,
- P Vedel,
- O Pedersen,
- and H H Parving
White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.
Diabetes Care May 1997 20:859-863; doi:10.2337/diacare.20.5.859
- Abstract
Select this article
- T Kobayashi,
- S Yabe,
- T Kikuchi,
- T Kanda,
- and I Kobayashi
Presence of anti-pituitary antibodies and GAD antibodies in NIDDM and IDDM.
Diabetes Care May 1997 20:864-866; doi:10.2337/diacare.20.5.864
- Abstract
Select this article
- C M Clark, Jr,
- C Qiu,
- B Amerman,
- B Porter,
- N Fineberg,
- S Aldasouqi,
- and A Golichowski
Gestational diabetes: should it be added to the syndrome of insulin resistance?
Diabetes Care May 1997 20:867-871; doi:10.2337/diacare.20.5.867
- Abstract
Select this article
- B M Rosenn,
- M Miodovnik,
- J C Khoury,
- and T A Siddiqi
Deficient counterregulation: a possible risk factor for excessive fetal growth in IDDM pregnancies.
Diabetes Care May 1997 20:872-874; doi:10.2337/diacare.20.5.872
- Abstract
Select this article
- A C Alting,
- R J Meijer,
- and E C van Beresteijn
Incomplete elimination of the ABBOS epitope of bovine serum albumin under simulated gastrointestinal conditions of infants.
Diabetes Care May 1997 20:875-880; doi:10.2337/diacare.20.5.875
- Abstract
Select this article
- E Christiansen,
- S Schnider,
- B Palmvig,
- E Tauber-Lassen,
- and O Pedersen
Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.
Diabetes Care May 1997 20:881-887; doi:10.2337/diacare.20.5.881
- Abstract
Select this article
- R Calafiore
Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM.
Diabetes Care May 1997 20:889-896; doi:10.2337/diacare.20.5.889
- Abstract
- D Hammond-McKibben and
- H M Dosch
Cow's milk, bovine serum albumin, and IDDM: can we settle the controversies?
Diabetes Care May 1997 20:897-901
- Z T Bloomgarden
The 32nd annual meeting of the European Association for the Study of Diabetes. Treatment of type I diabetes, hypoglycemia, retinopathy, nephropathy, and the genetics of complications.
Diabetes Care May 1997 20:902-904
- M Taniyama,
- A Kasuga,
- Y Suzuki,
- Y Ozawa,
- M Handa,
- A Kobayashi,
- and Y Ban
Absence of antibodies to ICA512/IA-2 in NIDDM patients with the mitochondrial DNA bp 3243 mutation.
Diabetes Care May 1997 20:905-906
- S Fava and
- J Azzopardi
Thrombolysis in diabetic patients with myocardial infarction.
Diabetes Care May 1997 20:906-907

The evolving care of diabetes. Models, managed care, and public health.

The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone.

Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM.

Diabetes in urban African-Americans. IX. Provider adherence to management protocols.

The impact of diabetes on survival among patients with first myocardial infarction.

Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects.

Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes.

Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control.

Model of complications of NIDDM. I. Model construction and assumptions.

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.

The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.

Clustering of childhood IDDM. Links with age and place of residence.

The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians.

The Problem Areas in Diabetes Scale. An evaluation of its clinical utility.

Bacille Calmette-Guérin vaccination and incidence of IDDM in Montreal, Canada.

Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas.

Observations of diabetes care in long-term institutional settings with measures of cognitive function and dependency.

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.

Insulin and cognitive function in an elderly population. The Rotterdam Study.

Symptom awareness is affected by the subjects' expectations during insulin-induced hypoglycemia.

Attentional functioning in children and adolescents with IDDM.

Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients.

Glycosaminoglycans delay the progression of nephropathy in NIDDM.

Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy.

Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM.

Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.

A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee.

Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications.

Gastric myoelectrical activity in patients with diabetes. Role of glucose control and autonomic nerve function.

The role of dynamic plantar pressures in diabetic foot ulcers.

White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.

Presence of anti-pituitary antibodies and GAD antibodies in NIDDM and IDDM.

Gestational diabetes: should it be added to the syndrome of insulin resistance?

Deficient counterregulation: a possible risk factor for excessive fetal growth in IDDM pregnancies.

Incomplete elimination of the ABBOS epitope of bovine serum albumin under simulated gastrointestinal conditions of infants.

Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.

Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM.

Cow's milk, bovine serum albumin, and IDDM: can we settle the controversies?

The 32nd annual meeting of the European Association for the Study of Diabetes. Treatment of type I diabetes, hypoglycemia, retinopathy, nephropathy, and the genetics of complications.

Absence of antibodies to ICA512/IA-2 in NIDDM patients with the mitochondrial DNA bp 3243 mutation.

Thrombolysis in diabetic patients with myocardial infarction.

This Issue

Current Issue

From the Cover